Leber Hereditary Optic Neuropathy G11778A Gene Therapy Clinical Trial: Stability of Clinical Parameters in Preparatory Phase Based on Onset of Visual Loss

Update Item Information
Identifier 20130212_nanos_sciplatform2_12
Title Leber Hereditary Optic Neuropathy G11778A Gene Therapy Clinical Trial: Stability of Clinical Parameters in Preparatory Phase Based on Onset of Visual Loss
Creator Byron L. Lam; John R. Guy; William J. Feuer; Vittorio Porciatti; Ruth Vandenbroucke; Joyce C. Schiffman
Affiliation (BLL) Bascom Palmer Eye Institute, University of Miami, Miami, FL
Subject Leber Hereditary Optic Neuropathy; Gene Therapy
Description The preparatory phase of the LHON gene therapy trial aims to characterize affected patients and carriers for the planned gene therapy study that will utilize 'allotopic expression' via an adeno-associated virus vector. We have followed the natural history of affected patients to characterize visual function outcome variables for the planned phase I and II studies.
Date 2013-02-12
Language eng
Format application/pdf
Type Text
Source 2013 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2013: Platform Presentations (Session II)
Collection Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 2013. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s6962q7z
Setname ehsl_novel_nam
ID 183293
Reference URL https://collections.lib.utah.edu/ark:/87278/s6962q7z
Back to Search Results